AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇰🇪
Amlodipine/Valsartan in Kenya
6 products registered with PPB — 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Exforge tablets 10/160mg Coated Tablet | H2007/17850/R1 | Novartis Pharma Services Inc | active | 26 Mar 2031 |
| Exforge tablets 5/160mg Coated Tablet | H2007/17849/R1 | Novartis Pharma Services Inc | active | 26 Mar 2031 |
| Amva Denk 5/80 mg Film-Coated Tablet | H2025/CTD7033/13450 | Denk Pharma GmbH & Co. KG | active | 17 Sept 2030 |
| Extor Tablets 5+80 Tablet | H2024/CTD9525/18571 | THE SEARLE COMPANY LIMITED | active | 28 Feb 2029 |
| Amva Denk 5/160 mg Film-Coated Tablet | H2022/CTD7047/13470 | Denk Pharma GmbH & Co. KG | active | 4 Aug 2028 |
| Amva Denk 10/160 mg Film-Coated Tablet | H2022/CTD7048/13471 | DENK PHARMA GmbH & Co. KG | active | 4 Aug 2028 |
Amlodipine/Valsartan — PPB Registration Details
PPB (Kenya) has 6 registered products containing Amlodipine/Valsartan, of which 6 are currently active. Data is sourced directly from the official PPB drug register and refreshed daily.
Track Amlodipine/Valsartan registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.